Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
2000 participants
OBSERVATIONAL
2016-08-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation
NCT03382613
The Jordan Atrial Fibrillation Study: Baseline Risk Scores and One Year Outcome
NCT03917992
Atrial Fibrillation General Registry
NCT02518984
Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial Fibrillation
NCT03964025
Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
NCT06833138
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AF cohort
AF consecutive patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* developing atrial fibrillation during hospitalization for mon AF reason.
* age 18 or more years.
* patients welling to participate in the registry.
Exclusion Criteria
* patients not welling to participate.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jordan Collaborating Cardiology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman J Hammoudeh, MD, FACC
Co- investigator with Munir Zaqqa, MD, FACC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Munir Zaqqa, MD FACC
Role: STUDY_DIRECTOR
Istishari Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istishari hospital
Amman, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JoAFR-JCCG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.